INS and diabetes mellitus: We first investigated various candidate antigens, including insulin, insulinoma antigen-2 (IA-2), and glutamic acid decarboxylase (GAD), that had been previously identified as autoantibody targets in diabetes but found that extracts and/or peptides of these proteins did not activate BDC T cells [7].